Gene expression profiling of transporters in the solute carrier and ATP-binding cassette superfamilies in human eye substructures.

The barrier epithelia of the cornea and retina control drug and nutrient access to various compartments of the human eye. While ocular transporters are likely to play a critical role in homeostasis and drug delivery, little is known about their expression, localization and function. In this study, the mRNA expression levels of 445 transporters, metabolic enzymes, transcription factors and nuclear receptors were profiled in five regions of the human eye: cornea, iris, ciliary body, choroid and retina. Through RNA expression profiling and immunohistochemistry, several transporters were identified as putative targets for drug transport in ocular tissues. Our analysis identified SLC22A7 (OAT2), a carrier for the antiviral drug acyclovir, in the corneal epithelium, in addition to ABCG2 (BCRP), an important xenobiotic efflux pump, in retinal nerve fibers and the retinal pigment epithelium. Collectively, our results provide an understanding of the transporters that serve to maintain ocular homeostasis and which may be potential targets for drug delivery to deep compartments of the eye.

[1]  Asim V. Farooq,et al.  Herpes simplex epithelial and stromal keratitis: an epidemiologic update. , 2012, Survey of ophthalmology.

[2]  C. Keilhauer,et al.  A subgroup of age-related macular degeneration is associated with mono-allelic sequence variants in the ABCA4 gene. , 2012, Investigative ophthalmology & visual science.

[3]  L. Aleksunes,et al.  Expression of Organic Anion Transporter 2 in the Human Kidney and Its Potential Role in the Tubular Secretion of Guanine-Containing Antiviral Drugs , 2012, Drug Metabolism and Disposition.

[4]  K. Kaarniranta,et al.  Efflux Protein Expression in Human Stem Cell-Derived Retinal Pigment Epithelial Cells , 2012, PloS one.

[5]  J. I. Korenbrot,et al.  Speed, adaptation, and stability of the response to light in cone photoreceptors: The functional role of Ca-dependent modulation of ligand sensitivity in cGMP-gated ion channels , 2012, The Journal of general physiology.

[6]  R. Bendayan,et al.  Expression of ATP-Binding Cassette Membrane Transporters in Rodent and Human Sertoli Cells: Relevance to the Permeability of Antiretroviral Therapy at the Blood-Testis Barrier , 2012, Journal of Pharmacology and Experimental Therapeutics.

[7]  I. Holland,et al.  ABC transporters, mechanisms and biology: an overview. , 2011, Essays in biochemistry.

[8]  M. Ott,et al.  The ABC of the blood-brain barrier - regulation of drug efflux pumps. , 2011, Current pharmaceutical design.

[9]  Gideon Koren,et al.  Acyclovir is a substrate for the human breast cancer resistance protein (BCRP/ABCG2): implications for renal tubular transport and acyclovir-induced nephrotoxicity. , 2011, Canadian journal of physiology and pharmacology.

[10]  R. Pelletier The blood-testis barrier: the junctional permeability, the proteins and the lipids. , 2011, Progress in histochemistry and cytochemistry.

[11]  J. Handa,et al.  Lipids, Lipoproteins, and Age-Related Macular Degeneration , 2011, Journal of lipids.

[12]  M. Daly,et al.  Association of variants in the LIPC and ABCA1 genes with intermediate and large drusen and advanced age-related macular degeneration. , 2011, Investigative ophthalmology & visual science.

[13]  V. Sheffield,et al.  Genomics and the eye. , 2011, The New England journal of medicine.

[14]  G. Quellec,et al.  Computational quantification of complex fundus phenotypes in age-related macular degeneration and Stargardt disease. , 2011, Investigative ophthalmology & visual science.

[15]  P. Elliott,et al.  Meta-Analysis of Genome-Wide Association Studies in >80 000 Subjects Identifies Multiple Loci for C-Reactive Protein Levels , 2011, Circulation.

[16]  C. Ramirez,et al.  Molecular genetic basis for fluoroquinolone-induced retinal degeneration in cats , 2011, Pharmacogenetics and genomics.

[17]  David J. Calkins,et al.  Brimonidine prevents axonal and somatic degeneration of retinal ganglion cell neurons , 2011, Molecular Neurodegeneration.

[18]  C. Dinarello,et al.  Blocking interleukin‐1β in acute and chronic autoinflammatory diseases , 2011, Journal of internal medicine.

[19]  A. Subrizi,et al.  Barrier analysis of periocular drug delivery to the posterior segment. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Akiyoshi Uemura,et al.  MRP4 knockdown enhances migration, suppresses apoptosis, and produces aggregated morphology in human retinal vascular endothelial cells. , 2010, Biochemical and biophysical research communications.

[21]  Ken-ichi Hosoya,et al.  The role of blood–ocular barrier transporters in retinal drug disposition: an overview , 2010, Expert opinion on drug metabolism & toxicology.

[22]  H. Glaeser,et al.  The prostaglandin transporter OATP2A1 is expressed in human ocular tissues and transports the antiglaucoma prostanoid latanoprost. , 2010, Investigative ophthalmology & visual science.

[23]  Margaret A. Pericak-Vance,et al.  Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.

[24]  M. Niemi,et al.  Membrane transporters in drug development , 2010, Nature Reviews Drug Discovery.

[25]  B. Ambati,et al.  Corneal transparency: Genesis, maintenance and dysfunction , 2010, Brain Research Bulletin.

[26]  M. Häkli,et al.  Effluxing ABC transporters in human corneal epithelium. , 2010, Journal of pharmaceutical sciences.

[27]  B. Hagenbuch Drug Uptake Systems in Liver and Kidney: A Historic Perspective , 2010, Clinical pharmacology and therapeutics.

[28]  P. Donnelly,et al.  Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region , 2010 .

[29]  A. Negi,et al.  Expression of ATP-binding cassette transporters at the inner blood–retinal barrier in a neonatal mouse model of oxygen-induced retinopathy , 2009, Brain Research.

[30]  J. Hohmann,et al.  Expression Profiling of the Solute Carrier Gene Family in the Mouse Brain , 2009, Journal of Pharmacology and Experimental Therapeutics.

[31]  G. Mishra,et al.  Enhanced Corneal Absorption of Erythromycin by Modulating P-Glycoprotein and MRP Mediated Efflux with Corticosteroids , 2009, Pharmaceutical Research.

[32]  K. Kaarniranta,et al.  Efflux Protein Expression in Human Retinal Pigment Epithelium Cell Lines , 2009, Pharmaceutical Research.

[33]  T. Terasaki,et al.  Roles of Inner Blood-Retinal Barrier Organic Anion Transporter 3 in the Vitreous/Retina-to-Blood Efflux Transport of p-Aminohippuric Acid, Benzylpenicillin, and 6-Mercaptopurine , 2009, Journal of Pharmacology and Experimental Therapeutics.

[34]  A. Mitra,et al.  Expression of multidrug resistance associated protein 5 (MRP5) on cornea and its role in drug efflux. , 2009, Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics.

[35]  M. Lavail,et al.  Expression of Reverse Cholesterol Transport Proteins Atp- Binding Cassette A1 (abca1) and Scavenger Receptor Bi (sr-bi) in the Retina and Retinal Pigment Epithelium Nih Public Access Author Manuscript $watermark-text , 2022 .

[36]  F. Russel,et al.  The Role of ATP Binding Cassette Transporters in Tissue Defense and Organ Regeneration , 2009, Journal of Pharmacology and Experimental Therapeutics.

[37]  A. Mitra,et al.  Molecular Expression and Functional Evidence of a Drug Efflux Pump (BCRP) in Human Corneal Epithelial Cells , 2009, Current eye research.

[38]  J. Weinstein,et al.  Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters , 2008, Molecular Cancer Therapeutics.

[39]  M. Hauser,et al.  NEIBank: Genomics and bioinformatics resources for vision research , 2008, Molecular vision.

[40]  Tao Zhang,et al.  Drug Transporter and Cytochrome P450 mRNA Expression in Human Ocular Barriers: Implications for Ocular Drug Disposition , 2008, Drug Metabolism and Disposition.

[41]  Swati S. More,et al.  Organic Anion Transporter 2 (SLC22A7) Is a Facilitative Transporter of cGMP , 2008, Molecular Pharmacology.

[42]  E. Petzinger,et al.  Molecular and phylogenetic characterization of a novel putative membrane transporter (SLC10A7), conserved in vertebrates and bacteria. , 2007, European journal of cell biology.

[43]  S. Nigam,et al.  Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissues , 2007, Nature Clinical Practice Nephrology.

[44]  Osamu Ogawa,et al.  Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. , 2007, Biochemical pharmacology.

[45]  R. Hevner,et al.  Expression and immunolocalization of the plasma membrane monoamine transporter in the brain , 2007, Neuroscience.

[46]  H. Stöhr,et al.  Bmc Molecular Biology Three Novel Abcc5 Splice Variants in Human Retina and Their Role as Regulators of Abcc5 Gene Expression , 2022 .

[47]  A. Mitra,et al.  Molecular evidence and functional expression of a novel drug efflux pump (ABCC2) in human corneal epithelium and rabbit cornea and its role in ocular drug efflux. , 2007, International journal of pharmaceutics.

[48]  Shiyao Xu,et al.  Transport of the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin by Human Organic Anion Transporter 3, Organic Anion Transporting Polypeptide 4C1, and Multidrug Resistance P-glycoprotein , 2007, Journal of Pharmacology and Experimental Therapeutics.

[49]  H. Kato,et al.  Modulation of drug-stimulated ATPase activity of human MDR1/P-glycoprotein by cholesterol. , 2007, The Biochemical journal.

[50]  Kati-Sisko Vellonen,et al.  Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. , 2006, Advanced drug delivery reviews.

[51]  V. Douet,et al.  HNF4alpha and NF-E2 are key transcriptional regulators of the murine Abcc6 gene expression. , 2006, Biochimica et biophysica acta.

[52]  B. Giros,et al.  Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain , 2006, Neuropharmacology.

[53]  Masahiko Watanabe,et al.  ATP-Binding Cassette Transporter G2 Mediates the Efflux of Phototoxins on the Luminal Membrane of Retinal Capillary Endothelial Cells , 2006, Pharmaceutical Research.

[54]  J. Wenzel,et al.  ABC A-subfamily transporters: structure, function and disease. , 2006, Biochimica et biophysica acta.

[55]  H. Sasaki,et al.  Transport of acebutolol through rabbit corneal epithelium. , 2006, Biological & pharmaceutical bulletin.

[56]  Brian R. Phillips,et al.  INTERACTIONS OF AMOXICILLIN AND CEFACLOR WITH HUMAN RENAL ORGANIC ANION AND PEPTIDE TRANSPORTERS , 2006, Drug Metabolism and Disposition.

[57]  Matthew W. Wilson,et al.  Immunohistochemical detection of multidrug-resistant protein expression in retinoblastoma treated by primary enucleation. , 2006, Investigative ophthalmology & visual science.

[58]  R. Neubert,et al.  Drug specificity and intestinal membrane localization of human organic cation transporters (OCT). , 2005, Biochemical pharmacology.

[59]  G. Abecasis,et al.  Toll-like receptor 4 variant D299G is associated with susceptibility to age-related macular degeneration. , 2005, Human molecular genetics.

[60]  Guy Perrière,et al.  MADE4: an R package for multivariate analysis of gene expression data , 2005, Bioinform..

[61]  Toshinori Yamamoto,et al.  Transport mechanism and substrate specificity of human organic anion transporter 2 (hOat2 [SLC22A7]) , 2005, The Journal of pharmacy and pharmacology.

[62]  Toshinori Yamamoto,et al.  POSSIBLE INVOLVEMENT OF ORGANIC ANION TRANSPORTER 2 ON THE INTERACTION OF THEOPHYLLINE WITH ERYTHROMYCIN IN THE HUMAN LIVER , 2005, Drug Metabolism and Disposition.

[63]  P. Meier,et al.  The Human Organic Anion Transporter 2 Gene Is Transactivated by Hepatocyte Nuclear Factor-4α and Suppressed by Bile Acids , 2005, Molecular Pharmacology.

[64]  E. Miserocchi,et al.  Comparison of the Efficacy of Valacyclovir vs Acyclovir for the Prevention of Recurrent Herpes Simplex Virus Eye Disease , 2005 .

[65]  A. Urtti,et al.  Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity. , 2005, Investigative ophthalmology & visual science.

[66]  G. You The role of organic ion transporters in drug disposition: an update. , 2004, Current drug metabolism.

[67]  Andreas Rolfs,et al.  The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteins , 2004, Pflügers Archiv.

[68]  Maristela L Onozato,et al.  Interaction of human and rat organic anion transporter 2 with various cephalosporin antibiotics. , 2003, European journal of pharmacology.

[69]  A. Schinkel,et al.  Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. , 2003, Advanced drug delivery reviews.

[70]  P. Meier,et al.  Transport of xenobiotics across the blood-brain barrier. , 2002, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.

[71]  O. Meijer,et al.  The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone. , 2002, The Journal of endocrinology.

[72]  A. Enomoto,et al.  Human organic anion transporters and human organic cation transporters mediate renal transport of prostaglandins. , 2002, The Journal of pharmacology and experimental therapeutics.

[73]  H. Endou,et al.  Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. , 2002, Journal of Pharmacology and Experimental Therapeutics.

[74]  S. Nigam,et al.  The organic anion transporter family: from physiology to ontogeny and the clinic. , 2001, American journal of physiology. Renal physiology.

[75]  M. Pfaffl,et al.  A new mathematical model for relative quantification in real-time RT-PCR. , 2001, Nucleic acids research.

[76]  Dao-Yi Yu,et al.  Oxygen Distribution and Consumption within the Retina in Vascularised and Avascular Retinas and in Animal Models of Retinal Disease , 2001, Progress in Retinal and Eye Research.

[77]  D. Hu,et al.  Characterization of a novel cationic drug transporter in human retinal pigment epithelial cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[78]  G. Szakács,et al.  MDR3 P-glycoprotein, a Phosphatidylcholine Translocase, Transports Several Cytotoxic Drugs and Directly Interacts with Drugs as Judged by Interference with Nucleotide Trapping* , 2000, The Journal of Biological Chemistry.

[79]  T. Cihlar,et al.  Fluorescence-based assay for the interaction of small molecules with the human renal organic anion transporter 1. , 2000, Analytical biochemistry.

[80]  T. Cihlar,et al.  Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. , 2000, Journal of the American Society of Nephrology : JASN.

[81]  V. Ganapathy,et al.  Expression of the extraneuronal monoamine transporter in RPE and neural retina , 2000, Current eye research.

[82]  J. Nezu,et al.  Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. , 1999, The Journal of pharmacology and experimental therapeutics.

[83]  T. Cihlar,et al.  The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. , 1999, Molecular pharmacology.

[84]  Kazuhito Yamada,et al.  Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin. , 1999, Investigative ophthalmology & visual science.

[85]  J. Nezu,et al.  Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations. , 1999, The Journal of pharmacology and experimental therapeutics.

[86]  P J Sinko,et al.  Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line. , 1999, The Journal of pharmacology and experimental therapeutics.

[87]  M. Prausnitz,et al.  Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. , 1998, Journal of pharmaceutical sciences.

[88]  A. Guo,et al.  Direct evidence for peptide transporter (PepT1)-mediated uptake of a nonpeptide prodrug, valacyclovir. , 1998, Biochemical and biophysical research communications.

[89]  R. D. Stulting,et al.  Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group. , 1998, The New England journal of medicine.

[90]  B. Hagenbuch Molecular Properties of Hepatic Uptake Systems for Bile Acids and Organic Anions , 1997, The Journal of Membrane Biology.

[91]  M. Dana,et al.  Immunity causing blindness: five different paths to herpes stromal keratitis. , 1997, Immunology today.

[92]  K. Kontturi,et al.  Characterization of paracellular and aqueous penetration routes in cornea, conjunctiva, and sclera. , 1997, Investigative ophthalmology & visual science.

[93]  W. Pardridge Advances in cell biology of blood-brain barrier transport. , 1991, Seminars in cell biology.

[94]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[95]  K. Yoshinari,et al.  Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA. , 2007, Drug metabolism and pharmacokinetics.

[96]  I. Tamai,et al.  Identification of influx transporter for the quinolone antibacterial agent levofloxacin. , 2007, Molecular pharmaceutics.

[97]  V. H. Lee,et al.  Characterization of brimonidine transport in retinal pigment epithelium. , 2006, Investigative ophthalmology & visual science.

[98]  A. Wenzel,et al.  Localization of organic anion transporting polypeptides in the rat and human ciliary body epithelium. , 2005, Experimental eye research.

[99]  M. Tomi,et al.  Advances in the cell biology of transport via the inner blood-retinal barrier: establishment of cell lines and transport functions. , 2005, Biological & pharmaceutical bulletin.

[100]  Joan W. Miller,et al.  Ocular Tissue Permeabilities , 2004, International ophthalmology clinics.

[101]  E. Babu,et al.  Human organic anion transporters mediate the transport of tetracycline. , 2002, Japanese journal of pharmacology.

[102]  P. Borst,et al.  Mammalian ABC transporters in health and disease. , 2002, Annual review of biochemistry.

[103]  H. Koepsell,et al.  Organic cation transporters in intestine, kidney, liver, and brain. , 1998, Annual review of physiology.

[104]  G. Bensi,et al.  Human interleukin-1 beta gene. , 1987, Gene.